World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
146
Citations
93433
World Ranking
133
National Ranking
89

Medicine

D-Index
146
Citations
93366
World Ranking
1323
National Ranking
764

Richard A. Koup publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard A. Koup sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 531 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard A. Koup D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard A. Koup sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 146 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Richard A. Koup is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Immunology, Virology, Epidemiology, and Radiology, Nuclear Medicine and Imaging.

Their work covers a range of main topics related to immunology and infectious disease control, including:

  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 Clinical Research Studies

The scientist has contributed to multiple publication venues, frequently publishing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • The Journal of Immunology
  • Nature Medicine
  • Science Translational Medicine

Notable recent papers authored or co-authored by Richard A. Koup include the following:

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial (2022), Science
  • Vaccination induces HIV broadly neutralizing antibody precursors in humans (2022), Science
  • A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines (2022), New England Journal of Medicine
  • Defining the risk of SARS-CoV-2 variants on immune protection (2022), Nature
  • Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice (2022), Nature Medicine

Frequent collaborators in research include:

  • Adrian B. McDermott
  • John R. Mascola
  • Peter D. Kwong
  • Nicole A. Doria-Rose
  • Amarendra Pegu

Richard A. Koup has also been recognized as a Member of the Association of American Physicians.

Best Publications

  • HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

    Tatjana Dragic;Virginia Litwin;Graham P. Allaway;Scott R. Martin

  • Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

    R. A. Koup;J. T. Safrit;Yunzhen Cao;C. A. Andrews

  • Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

    Rong Liu;William A Paxton;Sunny Choe;Daniel Ceradini

  • Changes in thymic function with age and during the treatment of HIV infection

    Daniel C. Douek;Richard D. McFarland;Phillip H. Keiser;Earl A. Gage

  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

    Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

    Michael R. Betts;Jason M. Brenchley;David A. Price;Stephen C. De Rosa

  • Genotypic and phenotypic characterization of HIV-1 patients with primary infection

    Tuofu Zhu;Hongmei Mo;Ning Wang;Daniel S. Nam

  • The role of a mutant CCR5 allele in HIV–1 transmission and disease progression

    Yaoxing Huang;William A. Paxton;Steven M. Wolinsky;Avidan U. Neumann

  • HIV preferentially infects HIV-specific CD4 + T cells

    Daniel C. Douek;Jason M. Brenchley;Michael R. Betts;David R. Ambrozak

  • Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

    Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar

  • Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

    Jason M. Brenchley;Nitin J. Karandikar;Michael R. Betts;David R. Ambrozak

  • PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

    Constantinos Petrovas;Joseph P. Casazza;Jason M. Brenchley;David A. Price

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

    Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong

  • HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

    Christine J. Pitcher;Claudia Quittner;Dolores M. Peterson;Mark Connors

  • Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

    Michael R. Betts;David R. Ambrozak;Daniel C. Douek;Sebastian Bonhoeffer

  • CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

    Lijun Wu;William A. Paxton;Nasim Kassam;Nancy Ruffing

  • Emerging Concepts in the Immunopathogenesis of AIDS

    Daniel C. Douek;Mario Roederer;Richard A. Koup

  • Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.

    Alexander I. Spira;Preston A. Marx;Bruce K. Patterson;James Mahoney

  • Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

    William A. Paxton;Scott R. Martin;Doris Tse;Thomas R. O'Brien

  • T Cell Dynamics in HIV-1 Infection*

    Daniel C. Douek;Louis J. Picker;Richard A. Koup

Frequent Co-Authors

Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
John R. Mascola
John R. Mascola ModeX Therapeutics
Daniel C. Douek
Daniel C. Douek National Institute of Allergy and Infectious Diseases
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
Adrian B. McDermott
Adrian B. McDermott National Institute of Allergy and Infectious Diseases
Michael R. Betts
Michael R. Betts University of Pennsylvania
Karin Loré
Karin Loré Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many aspiring healthcare professionals start with accessible programs, such as the easiest lpn programs to get into, which provide foundational nursing knowledge and patient care skills. These programs are often stepping stones to more advanced roles.

Nurse practitioners with a specialization in psychiatric and mental health play a vital role in immunology-related fields, especially in managing autoimmune and inflammatory conditions. To advance in this area, students might consider easiest nurse practitioner degree programs, allowing for efficient progression toward clinical practice.

Continuing education is essential, and the best programs offer strong clinical experience. The top pmhnp programs stand out for their high-quality clinical placements, ensuring students gain hands-on expertise necessary for patient care related to immunological health.

Cost is also a crucial factor. Aspiring professionals can find high-caliber education through cheapest pmhnp programs that balance affordability with comprehensive training, making advanced career pathways more accessible to a wider audience.

Best Scientists Citing Richard A. Koup

Trending Scientists

Recently Published Articles